Abstract
Objective and design
The present study aimed to investigate the relationship between the disturbed balance of CD4+/CD8+, Th17/Treg and the activation of the Notch signaling pathway in experimental autoimmune uveitis (EAU).
Methods
An EAU rat model was induced in Lewis rats, and pathology analysis was performed by hematoxylin and eosin (H&E) staining. CD4+, CD8+, Th17, and Treg levels in spleen, lymph nodes and eye tissues were determined by flow cytometry. Meanwhile, the expression of Notch1, DLL4, IL-10, and IL-17 was determined by quantitative polymerase chain reaction (Q-PCR) and enzyme-linked immunosorbent assay (ELISA). In addition, the inhibitory effect of N-(N-(3,5-difluorophenacetyl-l-alanyl))-S-phenylglycine t-butyl ester (DAPT) on Th17 differentiation by Notch signaling in vitro was further investigated using T lymphocytes from EAU rats on day 12 post-immunization by flow cytometry.
Results
The pathological results showed that inflammatory cell infiltration occurred in ocular tissues in EAU rats. The CD4+/CD8+ and Th17/Treg ratios in EAU rats were apparently higher than those in normal control individuals. Q-PCR and ELISA analyses indicated the expression of Notch1, DLL4, IL-10, and IL-17 in EAU rats gradually increased on day 6 after immunization, peaked on day 12, and then gradually decreased. The dynamic trends in Notch1 and DLL4 expression in EAU rats were identical to those of CD4+/CD8+ and Th17/Treg levels. DAPT can significantly inhibit the activation of Notch signaling, decrease Th17 cell differentiation, and attenuate the level of the Th17 cell lineage, contributing to the balance of the Th17/Treg ratio.
Conclusion
The activation of the Notch signaling pathway can regulate Th17 and Treg cell differentiation, disrupt the CD4+/CD8+ and Th17/Treg balance, and aggravate the severity of EAU; inactivation of the Notch signaling pathway contributes to the CD4+/CD8+ and Th17/Treg balance in EAU rats. Our findings highlighted that the dynamic change in the CD4+/CD8+ and Th17/Treg ratio was consistent with the expression trend of Notch signaling in EAU rats, suggesting that Notch signaling may be a potentially important therapeutic target in clinical practice.
Similar content being viewed by others
Abbreviations
- BD:
-
Behcet’s disease
- CFA:
-
Complete Freund’s adjuvant
- DAPT:
-
N-(N-(3,5-Difluorophenacetyl-l-alanyl))-S-phenylglycine t-butyl ester
- DMSO:
-
Dimethyl sulfoxide
- EAU:
-
Experimental autoimmune uveitis
- ELISA:
-
Enzyme-linked immunosorbent assay
- FBS:
-
Fetal bovine serum
- H&E:
-
Hematoxylin and eosin
- IFN-γ:
-
Interferon-γ
- IL-17:
-
Interleukin-17
- IRBP:
-
Interphotoreceptor retinoid-binding protein
- MCP-1:
-
Monocyte chemoattractant protein-1
- NC:
-
Normal control
- PBS:
-
Phosphate buffer saline
- Q-PCR:
-
Quantitative polymerase chain reaction
- TB:
-
Tuberculin
- TGF:
-
Transforming growth factor
- Th:
-
T helper
- TNF:
-
Tumor necrosis factor
References
Chen X, Vodanovic-Jankovic S, Johnson B, Keller M, Komorowski R, Drobyski WR. Absence of regulatory T cell control of TH1 and TH17 cells is responsible for the autoimmune- mediated pathology in chronic graft-versus-host disease. Blood. 2007;110(10):3804–13.
Hamzaoui K. Th17 cells in Behcet’s disease: a new immunoregulatory axis. Clin Exp Rheumatol. 2011;29(4 Suppl 67):S71–6.
Hsu YR, Chang SW, Lin YC, Yang CH. Expression of MicroRNAs in the eyes of lewis rats with experimental autoimmune anterior uveitis. Mediat Inflamm. 2015;2015:457835.
Weinstein JE, Pepple KL. Cytokines in uveitis. Curr Opin Ophthalmol. 2018;29(3):267–74.
Aktas Cetin E, Cosan F, Cefle A, Deniz G. IL-22-secreting Th22 and IFN-γ-secreting Th17 cells in Behcet’s disease. Mod Rheumatol. 2014;24(5):802–7.
Park H, Li Z, Yang XO, Chang SH, Nurieva R, Wang YH, Wang Y, Hood L, Zhu Z, Tian Q, Dong C. A distinct lineage of CD4+ T cells regulates tissue inflammation by producing interleukin 17. Nat Immunol. 2005;6:1133–41.
Cui Y, Shao H, Lan C, Nian H, O’Brien RL, Born WK, Kaplan HJ, Sun D. Major role of gamma delta T cells in the generation of IL-17 + uveitogenic T cells. J Immunol. 2009;183:560–7.
Forrester JV, Klaska IP, Yu T, Kuffova L. Uveitis in mouse and man. Int Rev Immunol. 2013;32(1):76–96.
Ahmadi M, Yousefi M, Abbaspour-Aghdam S, Dolati S, Aghebati-Maleki L, Eghbal-Fard S, Khabbazi A, Rostamzadeh D, Alipour S, Shabani M, Nouri M, Babaloo Z. Disturbed Th17/Treg balance, cytokines, and miRNAs in peripheral blood of patients with Behcet’s disease. J Cell Physiol. 2018. https://doi.org/10.1002/jcp.27207.
Dave N, Chevour P, Mahendradas P, Venkatesh A, Kawali A, Shetty R, Ghosh A, Sethu S. Increased aqueous humor CD4+/CD8+ lymphocyte ratio in sarcoid uveitis. Ocul Immunol Inflamm. 2018;8:1–8.
Jia X, Hu M, Wang C, Wang C, Zhang F, Han Q, Zhao R, Huang Q, Xu H, Yuan H, Ren H. Coordinated gene expression of Th17- and Treg-associated molecules correlated with resolution of the monophasic experimental autoimmune uveitis. Mol Vis. 2011;17:1493–507.
Romano M, Fanelli G, Tan N, Nova-Lamperti E, McGregor R, Lechler RI, Lombardi G, Scottà C. Expanded regulatory T cells induce alternatively activated monocytes with a reduced capacity to expand T helper-17 cells. Front Immunol. 2018;9:1625.
Diefenhardt P, Nosko A, Kluger MA, Richter JV, Wegscheid C, Kobayashi Y, Tiegs G, Huber S, Flavell RA, Stahl RAK, Steinmetz OM. IL-10 receptor signaling empowers regulatory T cells to control Th17 responses and protect from GN. J Am Soc Nephrol. 2018;29(7):1825–37.
Molins B, Mesquida M, Lee RW, Llorenç V, Pelegrín L, Adán A. Regulatory T cell levels and cytokine production in active non-infectious uveitis: in vitro effects of pharmacological treatment. Clin Exp Immunol. 2015;179(3):529–38.
Zhou ZY, Chen SL, Shen N, Lu Y. Cytokines and Behcet’s disease. Autoimmun Rev. 2012;11(10):699–704.
Tindemans I, Peeters MJW, Hendriks RW. Notch signaling in T helper cell subsets: instructor or unbiased amplifier? Front Immunol. 2017;18(8):419.
Qi J, Yang Y, Hou S, Qiao Y, Wang Q, Yu H, Zhang Q, Cai T, Kijlstra A, Yang P. Increased Notch pathway activation in Behcet’s disease. Rheumatology. 2014;53(5):810–20.
Rong H, Shen H, Xu Y. Yang Notch signalling suppresses regulatory T cell function in murine experimental autoimmune uveitis. Immunology. 2016;149(4):447–59.
Yoshimura T, Sonoda KH, Miyazaki Y, Iwakura Y, Ishibashi T, Yoshimura A, Yoshida H. Differential roles for IFN-gamma and IL-17 in experimental autoimmune uveoretinitis. Int Immunol. 2008;20:209–14.
Jha P, Manickam B, Matta B, Bora PS, Bora NS. Proteolytic cleavage of type I collagen generates an autoantigen in autoimmune uveitis. J Biol Chem. 2009;284(45):31401–11.
Crane IJ, Forrester JV. Th1 and Th2 lymphocytes in autoimmune disease. Crit Rev Immunol. 2005;25(2):75–102.
Caspi RR. Th1 and Th2 responses in pathogenesis and regulation of experimental autoimmune uveoretinitis. Int Rev Immunol. 2002;1:197–208.
Huang XT, Wang B, Zhang WH, Peng MQ. Lin D Total glucosides of paeony suppresses experimental autoimmune uveitis in association with inhibition of Th1 and Th2 cell function in mice. Int J Immunopathol Pharmacol. 2018. https://doi.org/10.1177/0394632017751547.
Hamzaoui K. Th17 cells in Behçet’s disease: a new immunoregulatory axis. Clin Exp Rheumatol. 2011;29(4 Suppl 67):S71–6.
Zhuang Z, Wang Y, Zhu G, Gu Y, Mao L, Hong M, Li Y, Zheng M. Imbalance of Th17/Treg cells in pathogenesis of patients with human leukocyte antigen B27 associated acute anterior uveitis. Sci Rep. 2017;7:40414.
Agarwal RK, Horai R, Viley AM, Silver PB, Grajewski RS, Su SB, Yazdani AT, Zhu W, Kronenberg M, Murray PJ, Rutschman RL, Chan CC, Caspi RR. Abrogation of anti-retinal autoimmunity in IL-10 transgenic mice due to reduced T cell priming and inhibition of disease effector mechanisms. J Immunol. 2008;180:5423–9.
Tang K, Guo D, Zhang L, Guo J, Zheng F, Si J, Bi H. Immunomodulatory effects of Long dan Xie gan Tang on CD4+/CD8+T cells and associated inflammatory cytokines in rats with experimental autoimmune uveitis. Mol Med Rep. 2016;14(3):2746–54.
Kaabachi W, Bouali E, Berraïes A, Dhifallh IB, Hamdi B, Hamzaoui K, Hamzaoui A. Interleukin-26 is overexpressed in Behcet’s disease and enhances Th17 related -cytokines. Immunol Lett. 2017;190:177–84.
Park YJ, Park MJ, Park S, Lee ES. CD11c is upregulated in CD8 + T cells of patients with Behcet’s disease. Clin Exp Rheumatol. 2016;34(6 Suppl 102):S86–91.
Yu CR, Dambuza IM, Lee YJ, Frank GM, Egwuagu CE. STAT3 regulates proliferation and survival of CD8 + T cells: enhances effector responses to HSV-1 infection, and inhibits IL-10 + regulatory CD8 + T cells in autoimmune uveitis. Mediat Inflamm. 2013;2013:359674.
Ueno A, Jeffery L, Kobayashi T, Hibi T, Ghosh S, Jijon H. Th17 plasticity and its relevance to inflammatory bowel disease. J Autoimmun. 2018;87:38–49.
Ivanova EA, Orekhov AN. T helper lymphocyte subsets and plasticity in autoimmunity and cancer: an overview. Biomed Res Int. 2015;2015:327470. https://doi.org/10.1155/2015/327470.
Kojima K, Maruyama K, Inaba T, Nagata K, Yasuhara T, Yoneda K, Sugita S, Mochizuki M, Kinoshita S. The CD4/CD8 ratio in vitreous fluid is of high diagnostic value in sarcoidosis. Ophthalmology. 2012;119:2386–92.
Sanz-Marco E, Garces M, Sempere A, Diaz-Llopis M. CD4/CD8 ratio in aqueous humor in Uveitis. Ocul Immunol Inflamm. 2013;21:408–9.
Li J, Qic C, Zhang Z, Yuan W, Ge z, Tan B, Yang P, Liu J, Zhu X, Qiu C, Lai D, Guo L, Yu L. Subretinal transplantation of human amniotic epithelial cells in the treatment of autoimmune uveitis in rats. Cell Transpl. 2018;27(10):1504–14.
Sharma RK, Gupta A, Kamal S, Bansal R, Singh N, Sharma K, Virk S, Sachdeva N. Role of regulatory T cells in tubercular uveitis. Ocul Immunol Inflamm. 2018;26(1):27–36.
Zhuang Z, Wang Y, Zhu G, Gu Y, Mao L, Hong M, Li Y, Zheng M. Imbalance of Th17/Treg cells in pathogenesis of patients with human leukocyte antigen B27associated acute anterior uveitis. Sci Rep. 2017;7:40414.
Ozen S, Eroglu FK. Pediatric-onset Behcet’s disease. Curr Opin Rheumatol. 2013;25(5):636–42.
Deniz R, Tulunay-Virlan A, Ture Ozdemir F, Unal AU, Ozen G, Alibaz-Oner F, Aydin-Tatli I, Mumcu G, Ergun T, Direskeneli H. Th17-inducing conditions lead to in vitro activation of both Th17 and Th1 responses in Behcet’s disease. Immunol Invest. 2017;46(5):518–25.
Fasching P, Stradner M, Graninger W, Dejaco C, Fessler J. Therapeutic potential of targeting the Th17/Treg axis in autoimmune disorders. Molecules. 2017;22(1):134.
Guedes MC, Borrego LM, Proença RD. Roles of interleukin-17 in uveitis. Indian J Ophthalmol. 2016;64(9):628–34.
Miyara M, Ito Y, Sakaguchi S. TREG-cell therapies for autoimmune rheumatic diseases. Nat Rev Rheumatol. 2014;10(9):543–51.
Gilbert RM, Zhang X, Sampson RD, Ehrenstein MR, Nguyen DX, Chaudhry M, Mein C, Mahmud N, Galatowicz G, Tomkins-Netzer O, Calder VL, Lightman S. Clinical remission of sight-threatening non-infectious uveitis is characterized by an upregulation of peripheral T regulatory cell polarized towards T bet and TIGIT. Front Immunol. 2018;9:907.
Zou W, Wu Z, Xiang X, Sun S, Zhang J. The expression and significance of T helper cell subsets and regulatory T cells CD4 + CD25 + in peripheral blood of patients with human leukocyte antigen B27-positive acute anterior uveitis. Graefes Arch Clin Exp Ophthalmol. 2014;252(4):665–72.
Wang Y, Xing F, Ye S, Xiao J, Di J, Zeng S, Liu J. Jagged-1 signaling suppresses the IL-6 and TGF-β treatment-induced Th17 cell differentiation via the reduction of ROR-γt/IL-17A/IL-17F/IL-23a/IL-12rb1. Sci Rep. 2015;5:8234.
Weng C, Chong L, Jia X, Zheng R, Huang Y, Zhu T, Li C, Zhang W. Anti-Dll4 antibody inhibits the differentiation of Th17 cells in asthmatic mice. Inflammation. 2017;40(6):1975–82.
Yang H, Zheng S, Mao Y, Chen Z, Zheng C, Li H, Sumners C, Li Q, Yang P, Lei B. Modulating of ocular inflammation with macrophage migration inhibitory factor is associated with notch signalling in experimental autoimmune uveitis. Clin Exp Immunol. 2016;183(2):280–93.
Bhuyan ZA, Asanoma M, Iwata A, Ishifune C, Maekawa Y, Shimada M, Yasutomo K. Abrogation of Rbpj attenuates experimental autoimmune uveoretinitis by inhibiting IL-22-producing CD4 + T cells. PLoS One. 2014;9(2):e89266.
Jiao Z, Wang W, Hua S, Liu M, Wang H, Wang X, Chen Y, Xu H, Lu L. Blockade of Notch signaling ameliorates murine collagen-induced arthritis via suppressing Th1 and Th17 cell responses. Am J Pathol. 2014;184(4):1085–93.
Yu S, Liu C, Li L, Tian T, Wang M, Hu Y, Yuan C, Zhang L, Ji C, Ma D. Inactivation of Notch signaling reverses the Th17/Treg imbalance in cells from patients with immune thrombocytopenia. Lab Invest. 2015;95(2):157–67.
Geri G, Terrier B, Rosenzwajg M, Wechsler B, Touzot M, Seilhean D, Tran TA, Bodaghi B, Musset L, Soumelis V, Klatzmann D, Cacoub P, Saadoun D. Critical role of IL-21 in modulating TH17 and regulatory T cells in Behçet disease. J Allergy Clin Immunol. 2011;128(3):655–64.
Qin L, Zhou YC, Wu HJ, Zhuo Y, Wang YP, Si CY, Qin YM. Notch signaling modulates the balance of regulatory T cells and T Helper 17 cells in Patients with chronic hepatitis C. DNA Cell Biol. 2017;36(4):311–20.
Jia X, Hu M, Wang C, Wang C, Zhang F, Han Q, Zhao R, Huang Q, Xu H, Yuan H, Ren H. Coordinated gene expression of Th17- and Treg-associated molecules correlated with resolution of the monophasic experimental autoimmune uveitis. Mol Vis. 2011;17:1493–507.
Kostianovsky AM, Maier LM, Baecher-Allan C, Anderson AC, Anderson DE. Up-regulation of gene related to anergy in lymphocytes is associated with Notch-mediated human T cell suppression. J Immunol. 2007;178(10):6158–63.
Acknowledgements
This study was supported by the National Natural Science Foundation of China (81873163), the Natural Science Foundation of Shandong Province (ZR2017LH042), Key Development & Research Program of Shandong Province (2016GGB14291), the Development Project of Medicine and Health Science Technology of Shandong Province (2013WS0251), and the Development Project of Science and Technology of Traditional Chinese Medicine of Shandong Province (2015-145).
Author information
Authors and Affiliations
Contributions
DG conceived and designed the study; XY, BL, HW, SW, FX, and LG performed the experiments; XY and TL analyzed the data; HB and DG contributed reagents/materials/analysis tools; XY and DG wrote the paper.
Corresponding author
Ethics declarations
Conflict of interest
The authors declare that they have no conflicting financial interests.
Additional information
Responsible Editor: John Di Battista.
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
About this article
Cite this article
Yin, X., Liu, B., Wei, H. et al. Activation of the Notch signaling pathway disturbs the CD4+/CD8+, Th17/Treg balance in rats with experimental autoimmune uveitis. Inflamm. Res. 68, 761–774 (2019). https://doi.org/10.1007/s00011-019-01260-w
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00011-019-01260-w